Carillon Tower Advisers’s Impax Laboratories, Inc. IPXL Stock Holding History

Carillon Tower Advisers’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-102,500	Closed	-$1.99M	–	524
2018 Q1	$1.99M	Buy	+102,500	New	+$2.01M	0.02%	433

Carillon Tower Advisers's IPXL Position: Q2 2018 in Review

Carillon Tower Advisers sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 102,500 shares — an estimated $1.99M sold.

Carillon Tower Advisers first reported a position in IPXL in Q1 2018 and held it in 1 quarter. The position peaked at $1.99M in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

Carillon Tower Advisers reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
Carillon Tower Advisers sold 102,500 Impax Laboratories, Inc. shares in Q2 2018, an estimated $1.99M.
Carillon Tower Advisers first reported a position in Impax Laboratories, Inc. in Q1 2018 and held it in 1 quarter.
Carillon Tower Advisers's Impax Laboratories, Inc. position peaked at $1.99M in Q1 2018.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Carillon Tower Advisers's 13F filing for Q2 2018, filed 9 Aug 2018.